EXALGO- hydromorphone hydrochloride tablet, extended release 
Mallinckrodt, Inc

----------

Medication Guide

EXALGO® (eks-al-goh)
(hydromorphone hydrochloride) Extended-Release Tablets, CII

EXALGO is:

Important information about EXALGO:

Do not take EXALGO if you have:

Before taking EXALGO, tell your healthcare provider if you have a history of:

Tell your healthcare provider if you are:

When taking EXALGO:

While taking EXALGO Do Not:

The possible side effects of EXALGO are:

Get emergency medical help if you have:

These are not all the possible side effects of EXALGO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. For more information go to dailymed.nlm.nih.gov

EXALGO is a registered trademark of Mallinckrodt LLC.

Distributed by: Mallinckrodt Brand Pharmaceuticals, Inc., Hazelwood, MO 63042 USA, www.Exalgo.com or call 1-800-778-7898                                                                         

Mallinckrodt

This Medication Guide has been approved by the U.S. Food and Drug Administration. Issue: July 2012 b

Revised: 03/2013
 
Mallinckrodt, Inc